Enzo Biochem, Inc. (ENZ)
NYSE: ENZ · Real-Time Price · USD
1.000
+0.013 (1.31%)
Nov 21, 2024, 10:56 AM EST - Market open

Enzo Biochem Revenue

In the fiscal year ending July 31, 2024, Enzo Biochem had annual revenue of $31.91M with 2.72% growth.

Revenue (ttm)
$31.91M
Revenue Growth
+2.72%
P/S Ratio
1.57
Revenue / Employee
$234,610
Employees
136
Market Cap
52.24M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Jul 31, 202431.91M846.00K2.72%
Jul 31, 202331.06M-1.58M-4.85%
Jul 31, 202232.64M-85.09M-72.27%
Jul 31, 2021117.73M41.71M54.87%
Jul 31, 202076.02M-5.15M-6.34%
Jul 31, 2019 Pro Pro Pro
Jul 31, 2018 Pro Pro Pro
Jul 31, 2017 Pro Pro Pro
Jul 31, 2016 Pro Pro Pro
Jul 31, 2015 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
111, Inc. 2.03B
LakeShore Biopharma 79.42M
Precision BioSciences 75.10M
Apyx Medical 48.54M
Cytosorbents 37.74M
BGM Group 29.87M
Kronos Bio 9.86M
Milestone Scientific 8.88M
Revenue Rankings